Global Traveler's Diarrhea Therapeutics Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Traveler's Diarrhea Therapeutics market size is predicted to grow from US$ 880 million in 2025 to US$ 1349 million in 2031; it is expected to grow at a CAGR of 7.4% from 2025 to 2031.
Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.
North America is the largest Traveler's Diarrhea Therapeutics market with about 45% market share. Europe is follower, accounting for about 42% market share.The key manufacturers are Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron etc. Top 3 companies occupied about 35% market share.
LP Information, Inc. (LPI) ' newest research report, the “Traveler's Diarrhea Therapeutics Industry Forecast” looks at past sales and reviews total world Traveler's Diarrhea Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Traveler's Diarrhea Therapeutics sales for 2025 through 2031. With Traveler's Diarrhea Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Traveler's Diarrhea Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Traveler's Diarrhea Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Traveler's Diarrhea Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Traveler's Diarrhea Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Traveler's Diarrhea Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Traveler's Diarrhea Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Traveler's Diarrhea Therapeutics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Traveler's Diarrhea Therapeutics market?
What factors are driving Traveler's Diarrhea Therapeutics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Traveler's Diarrhea Therapeutics market opportunities vary by end market size?
How does Traveler's Diarrhea Therapeutics break out by Type, by Application?
The global Traveler's Diarrhea Therapeutics market size is predicted to grow from US$ 880 million in 2025 to US$ 1349 million in 2031; it is expected to grow at a CAGR of 7.4% from 2025 to 2031.
Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week.
North America is the largest Traveler's Diarrhea Therapeutics market with about 45% market share. Europe is follower, accounting for about 42% market share.The key manufacturers are Salix Pharmaceuticals, P&G, Johnson & Johnson, Otsuka Pharma, Valneva, Shanghai United Cell, PaxVax, Livzon, Immuron etc. Top 3 companies occupied about 35% market share.
LP Information, Inc. (LPI) ' newest research report, the “Traveler's Diarrhea Therapeutics Industry Forecast” looks at past sales and reviews total world Traveler's Diarrhea Therapeutics sales in 2024, providing a comprehensive analysis by region and market sector of projected Traveler's Diarrhea Therapeutics sales for 2025 through 2031. With Traveler's Diarrhea Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Traveler's Diarrhea Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Traveler's Diarrhea Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Traveler's Diarrhea Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Traveler's Diarrhea Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Traveler's Diarrhea Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Traveler's Diarrhea Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Traveler's Diarrhea Therapeutics market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Immunization
- Non-antibiotic Agents
- Antibiotics
- Anti-Motility Agents
- Others
- Adult Traveler's Diarrhea
- Children Traveler's Diarrhea
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Salix Pharmaceuticals
- P&G
- Johnson & Johnson
- Otsuka Pharma
- Valneva
- Shanghai United Cell
- PaxVax
- Livzon
- Immuron
What is the 10-year outlook for the global Traveler's Diarrhea Therapeutics market?
What factors are driving Traveler's Diarrhea Therapeutics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Traveler's Diarrhea Therapeutics market opportunities vary by end market size?
How does Traveler's Diarrhea Therapeutics break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Traveler's Diarrhea Therapeutics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Traveler's Diarrhea Therapeutics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Traveler's Diarrhea Therapeutics by Country/Region, 2020, 2024 & 2031
2.2 Traveler's Diarrhea Therapeutics Segment by Type
2.2.1 Immunization
2.2.2 Non-antibiotic Agents
2.2.3 Antibiotics
2.2.4 Anti-Motility Agents
2.2.5 Others
2.3 Traveler's Diarrhea Therapeutics Sales by Type
2.3.1 Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2020-2025)
2.3.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Type (2020-2025)
2.3.3 Global Traveler's Diarrhea Therapeutics Sale Price by Type (2020-2025)
2.4 Traveler's Diarrhea Therapeutics Segment by Application
2.4.1 Adult Traveler's Diarrhea
2.4.2 Children Traveler's Diarrhea
2.5 Traveler's Diarrhea Therapeutics Sales by Application
2.5.1 Global Traveler's Diarrhea Therapeutics Sale Market Share by Application (2020-2025)
2.5.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Application (2020-2025)
2.5.3 Global Traveler's Diarrhea Therapeutics Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Traveler's Diarrhea Therapeutics Breakdown Data by Company
3.1.1 Global Traveler's Diarrhea Therapeutics Annual Sales by Company (2020-2025)
3.1.2 Global Traveler's Diarrhea Therapeutics Sales Market Share by Company (2020-2025)
3.2 Global Traveler's Diarrhea Therapeutics Annual Revenue by Company (2020-2025)
3.2.1 Global Traveler's Diarrhea Therapeutics Revenue by Company (2020-2025)
3.2.2 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Company (2020-2025)
3.3 Global Traveler's Diarrhea Therapeutics Sale Price by Company
3.4 Key Manufacturers Traveler's Diarrhea Therapeutics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Traveler's Diarrhea Therapeutics Product Location Distribution
3.4.2 Players Traveler's Diarrhea Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TRAVELER'S DIARRHEA THERAPEUTICS BY GEOGRAPHIC REGION
4.1 World Historic Traveler's Diarrhea Therapeutics Market Size by Geographic Region (2020-2025)
4.1.1 Global Traveler's Diarrhea Therapeutics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Traveler's Diarrhea Therapeutics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Traveler's Diarrhea Therapeutics Market Size by Country/Region (2020-2025)
4.2.1 Global Traveler's Diarrhea Therapeutics Annual Sales by Country/Region (2020-2025)
4.2.2 Global Traveler's Diarrhea Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Traveler's Diarrhea Therapeutics Sales Growth
4.4 APAC Traveler's Diarrhea Therapeutics Sales Growth
4.5 Europe Traveler's Diarrhea Therapeutics Sales Growth
4.6 Middle East & Africa Traveler's Diarrhea Therapeutics Sales Growth
5 AMERICAS
5.1 Americas Traveler's Diarrhea Therapeutics Sales by Country
5.1.1 Americas Traveler's Diarrhea Therapeutics Sales by Country (2020-2025)
5.1.2 Americas Traveler's Diarrhea Therapeutics Revenue by Country (2020-2025)
5.2 Americas Traveler's Diarrhea Therapeutics Sales by Type (2020-2025)
5.3 Americas Traveler's Diarrhea Therapeutics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Traveler's Diarrhea Therapeutics Sales by Region
6.1.1 APAC Traveler's Diarrhea Therapeutics Sales by Region (2020-2025)
6.1.2 APAC Traveler's Diarrhea Therapeutics Revenue by Region (2020-2025)
6.2 APAC Traveler's Diarrhea Therapeutics Sales by Type (2020-2025)
6.3 APAC Traveler's Diarrhea Therapeutics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Traveler's Diarrhea Therapeutics by Country
7.1.1 Europe Traveler's Diarrhea Therapeutics Sales by Country (2020-2025)
7.1.2 Europe Traveler's Diarrhea Therapeutics Revenue by Country (2020-2025)
7.2 Europe Traveler's Diarrhea Therapeutics Sales by Type (2020-2025)
7.3 Europe Traveler's Diarrhea Therapeutics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Traveler's Diarrhea Therapeutics by Country
8.1.1 Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Country (2020-2025)
8.1.2 Middle East & Africa Traveler's Diarrhea Therapeutics Revenue by Country (2020-2025)
8.2 Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Type (2020-2025)
8.3 Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Traveler's Diarrhea Therapeutics
10.3 Manufacturing Process Analysis of Traveler's Diarrhea Therapeutics
10.4 Industry Chain Structure of Traveler's Diarrhea Therapeutics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Traveler's Diarrhea Therapeutics Distributors
11.3 Traveler's Diarrhea Therapeutics Customer
12 WORLD FORECAST REVIEW FOR TRAVELER'S DIARRHEA THERAPEUTICS BY GEOGRAPHIC REGION
12.1 Global Traveler's Diarrhea Therapeutics Market Size Forecast by Region
12.1.1 Global Traveler's Diarrhea Therapeutics Forecast by Region (2026-2031)
12.1.2 Global Traveler's Diarrhea Therapeutics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Traveler's Diarrhea Therapeutics Forecast by Type (2026-2031)
12.7 Global Traveler's Diarrhea Therapeutics Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Salix Pharmaceuticals
13.1.1 Salix Pharmaceuticals Company Information
13.1.2 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.1.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Salix Pharmaceuticals Main Business Overview
13.1.5 Salix Pharmaceuticals Latest Developments
13.2 P&G
13.2.1 P&G Company Information
13.2.2 P&G Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.2.3 P&G Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 P&G Main Business Overview
13.2.5 P&G Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.3.3 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Otsuka Pharma
13.4.1 Otsuka Pharma Company Information
13.4.2 Otsuka Pharma Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.4.3 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Otsuka Pharma Main Business Overview
13.4.5 Otsuka Pharma Latest Developments
13.5 Valneva
13.5.1 Valneva Company Information
13.5.2 Valneva Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.5.3 Valneva Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Valneva Main Business Overview
13.5.5 Valneva Latest Developments
13.6 Shanghai United Cell
13.6.1 Shanghai United Cell Company Information
13.6.2 Shanghai United Cell Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.6.3 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Shanghai United Cell Main Business Overview
13.6.5 Shanghai United Cell Latest Developments
13.7 PaxVax
13.7.1 PaxVax Company Information
13.7.2 PaxVax Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.7.3 PaxVax Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 PaxVax Main Business Overview
13.7.5 PaxVax Latest Developments
13.8 Livzon
13.8.1 Livzon Company Information
13.8.2 Livzon Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.8.3 Livzon Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Livzon Main Business Overview
13.8.5 Livzon Latest Developments
13.9 Immuron
13.9.1 Immuron Company Information
13.9.2 Immuron Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.9.3 Immuron Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Immuron Main Business Overview
13.9.5 Immuron Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1.Traveler's DiarrheaTherapeutics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2.Traveler's DiarrheaTherapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Immunization
Table 4. Major Players of Non-antibiotic Agents
Table 5. Major Players of Antibiotics
Table 6. Major Players of Anti-Motility Agents
Table 7. Major Players of Others
Table 8. GlobalTraveler's DiarrheaTherapeutics Sales byType (2020-2025) & (K Units)
Table 9. GlobalTraveler's DiarrheaTherapeutics Sales Market Share byType (2020-2025)
Table 10. GlobalTraveler's DiarrheaTherapeutics Revenue byType (2020-2025) & ($ million)
Table 11. GlobalTraveler's DiarrheaTherapeutics Revenue Market Share byType (2020-2025)
Table 12. GlobalTraveler's DiarrheaTherapeutics Sale Price byType (2020-2025) & (USD/Unit)
Table 13. GlobalTraveler's DiarrheaTherapeutics Sale by Application (2020-2025) & (K Units)
Table 14. GlobalTraveler's DiarrheaTherapeutics Sale Market Share by Application (2020-2025)
Table 15. GlobalTraveler's DiarrheaTherapeutics Revenue by Application (2020-2025) & ($ million)
Table 16. GlobalTraveler's DiarrheaTherapeutics Revenue Market Share by Application (2020-2025)
Table 17. GlobalTraveler's DiarrheaTherapeutics Sale Price by Application (2020-2025) & (USD/Unit)
Table 18. GlobalTraveler's DiarrheaTherapeutics Sales by Company (2020-2025) & (K Units)
Table 19. GlobalTraveler's DiarrheaTherapeutics Sales Market Share by Company (2020-2025)
Table 20. GlobalTraveler's DiarrheaTherapeutics Revenue by Company (2020-2025) & ($ millions)
Table 21. GlobalTraveler's DiarrheaTherapeutics Revenue Market Share by Company (2020-2025)
Table 22. GlobalTraveler's DiarrheaTherapeutics Sale Price by Company (2020-2025) & (USD/Unit)
Table 23. Key ManufacturersTraveler's DiarrheaTherapeutics Producing Area Distribution and Sales Area
Table 24. PlayersTraveler's DiarrheaTherapeutics Products Offered
Table 25.Traveler's DiarrheaTherapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. GlobalTraveler's DiarrheaTherapeutics Sales by Geographic Region (2020-2025) & (K Units)
Table 29. GlobalTraveler's DiarrheaTherapeutics Sales Market Share Geographic Region (2020-2025)
Table 30. GlobalTraveler's DiarrheaTherapeutics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. GlobalTraveler's DiarrheaTherapeutics Revenue Market Share by Geographic Region (2020-2025)
Table 32. GlobalTraveler's DiarrheaTherapeutics Sales by Country/Region (2020-2025) & (K Units)
Table 33. GlobalTraveler's DiarrheaTherapeutics Sales Market Share by Country/Region (2020-2025)
Table 34. GlobalTraveler's DiarrheaTherapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. GlobalTraveler's DiarrheaTherapeutics Revenue Market Share by Country/Region (2020-2025)
Table 36. AmericasTraveler's DiarrheaTherapeutics Sales by Country (2020-2025) & (K Units)
Table 37. AmericasTraveler's DiarrheaTherapeutics Sales Market Share by Country (2020-2025)
Table 38. AmericasTraveler's DiarrheaTherapeutics Revenue by Country (2020-2025) & ($ millions)
Table 39. AmericasTraveler's DiarrheaTherapeutics Sales byType (2020-2025) & (K Units)
Table 40. AmericasTraveler's DiarrheaTherapeutics Sales by Application (2020-2025) & (K Units)
Table 41. APACTraveler's DiarrheaTherapeutics Sales by Region (2020-2025) & (K Units)
Table 42. APACTraveler's DiarrheaTherapeutics Sales Market Share by Region (2020-2025)
Table 43. APACTraveler's DiarrheaTherapeutics Revenue by Region (2020-2025) & ($ millions)
Table 44. APACTraveler's DiarrheaTherapeutics Sales byType (2020-2025) & (K Units)
Table 45. APACTraveler's DiarrheaTherapeutics Sales by Application (2020-2025) & (K Units)
Table 46. EuropeTraveler's DiarrheaTherapeutics Sales by Country (2020-2025) & (K Units)
Table 47. EuropeTraveler's DiarrheaTherapeutics Revenue by Country (2020-2025) & ($ millions)
Table 48. EuropeTraveler's DiarrheaTherapeutics Sales byType (2020-2025) & (K Units)
Table 49. EuropeTraveler's DiarrheaTherapeutics Sales by Application (2020-2025) & (K Units)
Table 50. Middle East & AfricaTraveler's DiarrheaTherapeutics Sales by Country (2020-2025) & (K Units)
Table 51. Middle East & AfricaTraveler's DiarrheaTherapeutics Revenue Market Share by Country (2020-2025)
Table 52. Middle East & AfricaTraveler's DiarrheaTherapeutics Sales byType (2020-2025) & (K Units)
Table 53. Middle East & AfricaTraveler's DiarrheaTherapeutics Sales by Application (2020-2025) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities ofTraveler's DiarrheaTherapeutics
Table 55. Key Market Challenges & Risks ofTraveler's DiarrheaTherapeutics
Table 56. Key IndustryTrends ofTraveler's DiarrheaTherapeutics
Table 57.Traveler's DiarrheaTherapeutics Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59.Traveler's DiarrheaTherapeutics Distributors List
Table 60.Traveler's DiarrheaTherapeutics Customer List
Table 61. GlobalTraveler's DiarrheaTherapeutics SalesForecast by Region (2026-2031) & (K Units)
Table 62. GlobalTraveler's DiarrheaTherapeutics RevenueForecast by Region (2026-2031) & ($ millions)
Table 63. AmericasTraveler's DiarrheaTherapeutics SalesForecast by Country (2026-2031) & (K Units)
Table 64. AmericasTraveler's DiarrheaTherapeutics Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 65. APACTraveler's DiarrheaTherapeutics SalesForecast by Region (2026-2031) & (K Units)
Table 66. APACTraveler's DiarrheaTherapeutics Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 67. EuropeTraveler's DiarrheaTherapeutics SalesForecast by Country (2026-2031) & (K Units)
Table 68. EuropeTraveler's DiarrheaTherapeutics RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & AfricaTraveler's DiarrheaTherapeutics SalesForecast by Country (2026-2031) & (K Units)
Table 70. Middle East & AfricaTraveler's DiarrheaTherapeutics RevenueForecast by Country (2026-2031) & ($ millions)
Table 71. GlobalTraveler's DiarrheaTherapeutics SalesForecast byType (2026-2031) & (K Units)
Table 72. GlobalTraveler's DiarrheaTherapeutics RevenueForecast byType (2026-2031) & ($ millions)
Table 73. GlobalTraveler's DiarrheaTherapeutics SalesForecast by Application (2026-2031) & (K Units)
Table 74. GlobalTraveler's DiarrheaTherapeutics RevenueForecast by Application (2026-2031) & ($ millions)
Table 75. Salix Pharmaceuticals Basic Information,Traveler's DiarrheaTherapeutics Manufacturing Base, Sales Area and Its Competitors
Table 76. Salix PharmaceuticalsTraveler's DiarrheaTherapeutics Product Portfolios and Specifications
Table 77. Salix PharmaceuticalsTraveler's DiarrheaTherapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Salix Pharmaceuticals Main Business
Table 79. Salix Pharmaceuticals Latest Developments
Table 80. P&G Basic Information,Traveler's DiarrheaTherapeutics Manufacturing Base, Sales Area and Its Competitors
Table 81. P>raveler's DiarrheaTherapeutics Product Portfolios and Specifications
Table 82. P>raveler's DiarrheaTherapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. P&G Main Business
Table 84. P&G Latest Developments
Table 85. Johnson & Johnson Basic Information,Traveler's DiarrheaTherapeutics Manufacturing Base, Sales Area and Its Competitors
Table 86. Johnson & JohnsonTraveler's DiarrheaTherapeutics Product Portfolios and Specifications
Table 87. Johnson & JohnsonTraveler's DiarrheaTherapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Johnson & Johnson Main Business
Table 89. Johnson & Johnson Latest Developments
Table 90. Otsuka Pharma Basic Information,Traveler's DiarrheaTherapeutics Manufacturing Base, Sales Area and Its Competitors
Table 91. Otsuka PharmaTraveler's DiarrheaTherapeutics Product Portfolios and Specifications
Table 92. Otsuka PharmaTraveler's DiarrheaTherapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Otsuka Pharma Main Business
Table 94. Otsuka Pharma Latest Developments
Table 95. Valneva Basic Information,Traveler's DiarrheaTherapeutics Manufacturing Base, Sales Area and Its Competitors
Table 96. ValnevaTraveler's DiarrheaTherapeutics Product Portfolios and Specifications
Table 97. ValnevaTraveler's DiarrheaTherapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Valneva Main Business
Table 99. Valneva Latest Developments
Table 100. Shanghai United Cell Basic Information,Traveler's DiarrheaTherapeutics Manufacturing Base, Sales Area and Its Competitors
Table 101. Shanghai United CellTraveler's DiarrheaTherapeutics Product Portfolios and Specifications
Table 102. Shanghai United CellTraveler's DiarrheaTherapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Shanghai United Cell Main Business
Table 104. Shanghai United Cell Latest Developments
Table 105. PaxVax Basic Information,Traveler's DiarrheaTherapeutics Manufacturing Base, Sales Area and Its Competitors
Table 106. PaxVaxTraveler's DiarrheaTherapeutics Product Portfolios and Specifications
Table 107. PaxVaxTraveler's DiarrheaTherapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. PaxVax Main Business
Table 109. PaxVax Latest Developments
Table 110. Livzon Basic Information,Traveler's DiarrheaTherapeutics Manufacturing Base, Sales Area and Its Competitors
Table 111. LivzonTraveler's DiarrheaTherapeutics Product Portfolios and Specifications
Table 112. LivzonTraveler's DiarrheaTherapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Livzon Main Business
Table 114. Livzon Latest Developments
Table 115. Immuron Basic Information,Traveler's DiarrheaTherapeutics Manufacturing Base, Sales Area and Its Competitors
Table 116. ImmuronTraveler's DiarrheaTherapeutics Product Portfolios and Specifications
Table 117. ImmuronTraveler's DiarrheaTherapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Immuron Main Business
Table 119. Immuron Latest Developments
LIST OFFIGURES
Figure 1. Picture ofTraveler's DiarrheaTherapeutics
Figure 2.Traveler's DiarrheaTherapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalTraveler's DiarrheaTherapeutics Sales Growth Rate 2020-2031 (K Units)
Figure 7. GlobalTraveler's DiarrheaTherapeutics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8.Traveler's DiarrheaTherapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9.Traveler's DiarrheaTherapeutics Sales Market Share by Country/Region (2024)
Figure 10.Traveler's DiarrheaTherapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Immunization
Figure 12. Product Picture of Non-antibiotic Agents
Figure 13. Product Picture of Antibiotics
Figure 14. Product Picture of Anti-Motility Agents
Figure 15. Product Picture of Others
Figure 16. GlobalTraveler's DiarrheaTherapeutics Sales Market Share byType in 2025
Figure 17. GlobalTraveler's DiarrheaTherapeutics Revenue Market Share byType (2020-2025)
Figure 18.Traveler's DiarrheaTherapeutics Consumed in AdultTraveler's Diarrhea
Figure 19. GlobalTraveler's DiarrheaTherapeutics Market: AdultTraveler's Diarrhea (2020-2025) & (K Units)
Figure 20.Traveler's DiarrheaTherapeutics Consumed in ChildrenTraveler's Diarrhea
Figure 21. GlobalTraveler's DiarrheaTherapeutics Market: ChildrenTraveler's Diarrhea (2020-2025) & (K Units)
Figure 22. GlobalTraveler's DiarrheaTherapeutics Sale Market Share by Application (2024)
Figure 23. GlobalTraveler's DiarrheaTherapeutics Revenue Market Share by Application in 2025
Figure 24.Traveler's DiarrheaTherapeutics Sales by Company in 2025 (K Units)
Figure 25. GlobalTraveler's DiarrheaTherapeutics Sales Market Share by Company in 2025
Figure 26.Traveler's DiarrheaTherapeutics Revenue by Company in 2025 ($ millions)
Figure 27. GlobalTraveler's DiarrheaTherapeutics Revenue Market Share by Company in 2025
Figure 28. GlobalTraveler's DiarrheaTherapeutics Sales Market Share by Geographic Region (2020-2025)
Figure 29. GlobalTraveler's DiarrheaTherapeutics Revenue Market Share by Geographic Region in 2025
Figure 30. AmericasTraveler's DiarrheaTherapeutics Sales 2020-2025 (K Units)
Figure 31. AmericasTraveler's DiarrheaTherapeutics Revenue 2020-2025 ($ millions)
Figure 32. APACTraveler's DiarrheaTherapeutics Sales 2020-2025 (K Units)
Figure 33. APACTraveler's DiarrheaTherapeutics Revenue 2020-2025 ($ millions)
Figure 34. EuropeTraveler's DiarrheaTherapeutics Sales 2020-2025 (K Units)
Figure 35. EuropeTraveler's DiarrheaTherapeutics Revenue 2020-2025 ($ millions)
Figure 36. Middle East & AfricaTraveler's DiarrheaTherapeutics Sales 2020-2025 (K Units)
Figure 37. Middle East & AfricaTraveler's DiarrheaTherapeutics Revenue 2020-2025 ($ millions)
Figure 38. AmericasTraveler's DiarrheaTherapeutics Sales Market Share by Country in 2025
Figure 39. AmericasTraveler's DiarrheaTherapeutics Revenue Market Share by Country (2020-2025)
Figure 40. AmericasTraveler's DiarrheaTherapeutics Sales Market Share byType (2020-2025)
Figure 41. AmericasTraveler's DiarrheaTherapeutics Sales Market Share by Application (2020-2025)
Figure 42. United StatesTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 43. CanadaTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 44. MexicoTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 45. BrazilTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 46. APACTraveler's DiarrheaTherapeutics Sales Market Share by Region in 2025
Figure 47. APACTraveler's DiarrheaTherapeutics Revenue Market Share by Region (2020-2025)
Figure 48. APACTraveler's DiarrheaTherapeutics Sales Market Share byType (2020-2025)
Figure 49. APACTraveler's DiarrheaTherapeutics Sales Market Share by Application (2020-2025)
Figure 50. ChinaTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 51. JapanTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 52. South KoreaTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast AsiaTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 54. IndiaTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 55. AustraliaTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwanTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 57. EuropeTraveler's DiarrheaTherapeutics Sales Market Share by Country in 2025
Figure 58. EuropeTraveler's DiarrheaTherapeutics Revenue Market Share by Country (2020-2025)
Figure 59. EuropeTraveler's DiarrheaTherapeutics Sales Market Share byType (2020-2025)
Figure 60. EuropeTraveler's DiarrheaTherapeutics Sales Market Share by Application (2020-2025)
Figure 61. GermanyTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 62.FranceTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 63. UKTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 64. ItalyTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 65. RussiaTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & AfricaTraveler's DiarrheaTherapeutics Sales Market Share by Country (2020-2025)
Figure 67. Middle East & AfricaTraveler's DiarrheaTherapeutics Sales Market Share byType (2020-2025)
Figure 68. Middle East & AfricaTraveler's DiarrheaTherapeutics Sales Market Share by Application (2020-2025)
Figure 69. EgyptTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 70. South AfricaTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 71. IsraelTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 72.TurkeyTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC CountriesTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis ofTraveler's DiarrheaTherapeutics in 2025
Figure 75. Manufacturing Process Analysis ofTraveler's DiarrheaTherapeutics
Figure 76. Industry Chain Structure ofTraveler's DiarrheaTherapeutics
Figure 77. Channels of Distribution
Figure 78. GlobalTraveler's DiarrheaTherapeutics Sales MarketForecast by Region (2026-2031)
Figure 79. GlobalTraveler's DiarrheaTherapeutics Revenue Market ShareForecast by Region (2026-2031)
Figure 80. GlobalTraveler's DiarrheaTherapeutics Sales Market ShareForecast byType (2026-2031)
Figure 81. GlobalTraveler's DiarrheaTherapeutics Revenue Market ShareForecast byType (2026-2031)
Figure 82. GlobalTraveler's DiarrheaTherapeutics Sales Market ShareForecast by Application (2026-2031)
Figure 83. GlobalTraveler's DiarrheaTherapeutics Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Traveler's Diarrhea Therapeutics Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Traveler's Diarrhea Therapeutics by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Traveler's Diarrhea Therapeutics by Country/Region, 2020, 2024 & 2031
2.2 Traveler's Diarrhea Therapeutics Segment by Type
2.2.1 Immunization
2.2.2 Non-antibiotic Agents
2.2.3 Antibiotics
2.2.4 Anti-Motility Agents
2.2.5 Others
2.3 Traveler's Diarrhea Therapeutics Sales by Type
2.3.1 Global Traveler's Diarrhea Therapeutics Sales Market Share by Type (2020-2025)
2.3.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Type (2020-2025)
2.3.3 Global Traveler's Diarrhea Therapeutics Sale Price by Type (2020-2025)
2.4 Traveler's Diarrhea Therapeutics Segment by Application
2.4.1 Adult Traveler's Diarrhea
2.4.2 Children Traveler's Diarrhea
2.5 Traveler's Diarrhea Therapeutics Sales by Application
2.5.1 Global Traveler's Diarrhea Therapeutics Sale Market Share by Application (2020-2025)
2.5.2 Global Traveler's Diarrhea Therapeutics Revenue and Market Share by Application (2020-2025)
2.5.3 Global Traveler's Diarrhea Therapeutics Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Traveler's Diarrhea Therapeutics Breakdown Data by Company
3.1.1 Global Traveler's Diarrhea Therapeutics Annual Sales by Company (2020-2025)
3.1.2 Global Traveler's Diarrhea Therapeutics Sales Market Share by Company (2020-2025)
3.2 Global Traveler's Diarrhea Therapeutics Annual Revenue by Company (2020-2025)
3.2.1 Global Traveler's Diarrhea Therapeutics Revenue by Company (2020-2025)
3.2.2 Global Traveler's Diarrhea Therapeutics Revenue Market Share by Company (2020-2025)
3.3 Global Traveler's Diarrhea Therapeutics Sale Price by Company
3.4 Key Manufacturers Traveler's Diarrhea Therapeutics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Traveler's Diarrhea Therapeutics Product Location Distribution
3.4.2 Players Traveler's Diarrhea Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR TRAVELER'S DIARRHEA THERAPEUTICS BY GEOGRAPHIC REGION
4.1 World Historic Traveler's Diarrhea Therapeutics Market Size by Geographic Region (2020-2025)
4.1.1 Global Traveler's Diarrhea Therapeutics Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Traveler's Diarrhea Therapeutics Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Traveler's Diarrhea Therapeutics Market Size by Country/Region (2020-2025)
4.2.1 Global Traveler's Diarrhea Therapeutics Annual Sales by Country/Region (2020-2025)
4.2.2 Global Traveler's Diarrhea Therapeutics Annual Revenue by Country/Region (2020-2025)
4.3 Americas Traveler's Diarrhea Therapeutics Sales Growth
4.4 APAC Traveler's Diarrhea Therapeutics Sales Growth
4.5 Europe Traveler's Diarrhea Therapeutics Sales Growth
4.6 Middle East & Africa Traveler's Diarrhea Therapeutics Sales Growth
5 AMERICAS
5.1 Americas Traveler's Diarrhea Therapeutics Sales by Country
5.1.1 Americas Traveler's Diarrhea Therapeutics Sales by Country (2020-2025)
5.1.2 Americas Traveler's Diarrhea Therapeutics Revenue by Country (2020-2025)
5.2 Americas Traveler's Diarrhea Therapeutics Sales by Type (2020-2025)
5.3 Americas Traveler's Diarrhea Therapeutics Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Traveler's Diarrhea Therapeutics Sales by Region
6.1.1 APAC Traveler's Diarrhea Therapeutics Sales by Region (2020-2025)
6.1.2 APAC Traveler's Diarrhea Therapeutics Revenue by Region (2020-2025)
6.2 APAC Traveler's Diarrhea Therapeutics Sales by Type (2020-2025)
6.3 APAC Traveler's Diarrhea Therapeutics Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Traveler's Diarrhea Therapeutics by Country
7.1.1 Europe Traveler's Diarrhea Therapeutics Sales by Country (2020-2025)
7.1.2 Europe Traveler's Diarrhea Therapeutics Revenue by Country (2020-2025)
7.2 Europe Traveler's Diarrhea Therapeutics Sales by Type (2020-2025)
7.3 Europe Traveler's Diarrhea Therapeutics Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Traveler's Diarrhea Therapeutics by Country
8.1.1 Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Country (2020-2025)
8.1.2 Middle East & Africa Traveler's Diarrhea Therapeutics Revenue by Country (2020-2025)
8.2 Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Type (2020-2025)
8.3 Middle East & Africa Traveler's Diarrhea Therapeutics Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Traveler's Diarrhea Therapeutics
10.3 Manufacturing Process Analysis of Traveler's Diarrhea Therapeutics
10.4 Industry Chain Structure of Traveler's Diarrhea Therapeutics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Traveler's Diarrhea Therapeutics Distributors
11.3 Traveler's Diarrhea Therapeutics Customer
12 WORLD FORECAST REVIEW FOR TRAVELER'S DIARRHEA THERAPEUTICS BY GEOGRAPHIC REGION
12.1 Global Traveler's Diarrhea Therapeutics Market Size Forecast by Region
12.1.1 Global Traveler's Diarrhea Therapeutics Forecast by Region (2026-2031)
12.1.2 Global Traveler's Diarrhea Therapeutics Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Traveler's Diarrhea Therapeutics Forecast by Type (2026-2031)
12.7 Global Traveler's Diarrhea Therapeutics Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Salix Pharmaceuticals
13.1.1 Salix Pharmaceuticals Company Information
13.1.2 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.1.3 Salix Pharmaceuticals Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Salix Pharmaceuticals Main Business Overview
13.1.5 Salix Pharmaceuticals Latest Developments
13.2 P&G
13.2.1 P&G Company Information
13.2.2 P&G Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.2.3 P&G Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 P&G Main Business Overview
13.2.5 P&G Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.3.3 Johnson & Johnson Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Otsuka Pharma
13.4.1 Otsuka Pharma Company Information
13.4.2 Otsuka Pharma Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.4.3 Otsuka Pharma Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Otsuka Pharma Main Business Overview
13.4.5 Otsuka Pharma Latest Developments
13.5 Valneva
13.5.1 Valneva Company Information
13.5.2 Valneva Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.5.3 Valneva Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Valneva Main Business Overview
13.5.5 Valneva Latest Developments
13.6 Shanghai United Cell
13.6.1 Shanghai United Cell Company Information
13.6.2 Shanghai United Cell Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.6.3 Shanghai United Cell Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Shanghai United Cell Main Business Overview
13.6.5 Shanghai United Cell Latest Developments
13.7 PaxVax
13.7.1 PaxVax Company Information
13.7.2 PaxVax Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.7.3 PaxVax Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 PaxVax Main Business Overview
13.7.5 PaxVax Latest Developments
13.8 Livzon
13.8.1 Livzon Company Information
13.8.2 Livzon Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.8.3 Livzon Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Livzon Main Business Overview
13.8.5 Livzon Latest Developments
13.9 Immuron
13.9.1 Immuron Company Information
13.9.2 Immuron Traveler's Diarrhea Therapeutics Product Portfolios and Specifications
13.9.3 Immuron Traveler's Diarrhea Therapeutics Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Immuron Main Business Overview
13.9.5 Immuron Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1.Traveler's DiarrheaTherapeutics Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2.Traveler's DiarrheaTherapeutics Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Immunization
Table 4. Major Players of Non-antibiotic Agents
Table 5. Major Players of Antibiotics
Table 6. Major Players of Anti-Motility Agents
Table 7. Major Players of Others
Table 8. GlobalTraveler's DiarrheaTherapeutics Sales byType (2020-2025) & (K Units)
Table 9. GlobalTraveler's DiarrheaTherapeutics Sales Market Share byType (2020-2025)
Table 10. GlobalTraveler's DiarrheaTherapeutics Revenue byType (2020-2025) & ($ million)
Table 11. GlobalTraveler's DiarrheaTherapeutics Revenue Market Share byType (2020-2025)
Table 12. GlobalTraveler's DiarrheaTherapeutics Sale Price byType (2020-2025) & (USD/Unit)
Table 13. GlobalTraveler's DiarrheaTherapeutics Sale by Application (2020-2025) & (K Units)
Table 14. GlobalTraveler's DiarrheaTherapeutics Sale Market Share by Application (2020-2025)
Table 15. GlobalTraveler's DiarrheaTherapeutics Revenue by Application (2020-2025) & ($ million)
Table 16. GlobalTraveler's DiarrheaTherapeutics Revenue Market Share by Application (2020-2025)
Table 17. GlobalTraveler's DiarrheaTherapeutics Sale Price by Application (2020-2025) & (USD/Unit)
Table 18. GlobalTraveler's DiarrheaTherapeutics Sales by Company (2020-2025) & (K Units)
Table 19. GlobalTraveler's DiarrheaTherapeutics Sales Market Share by Company (2020-2025)
Table 20. GlobalTraveler's DiarrheaTherapeutics Revenue by Company (2020-2025) & ($ millions)
Table 21. GlobalTraveler's DiarrheaTherapeutics Revenue Market Share by Company (2020-2025)
Table 22. GlobalTraveler's DiarrheaTherapeutics Sale Price by Company (2020-2025) & (USD/Unit)
Table 23. Key ManufacturersTraveler's DiarrheaTherapeutics Producing Area Distribution and Sales Area
Table 24. PlayersTraveler's DiarrheaTherapeutics Products Offered
Table 25.Traveler's DiarrheaTherapeutics Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. GlobalTraveler's DiarrheaTherapeutics Sales by Geographic Region (2020-2025) & (K Units)
Table 29. GlobalTraveler's DiarrheaTherapeutics Sales Market Share Geographic Region (2020-2025)
Table 30. GlobalTraveler's DiarrheaTherapeutics Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. GlobalTraveler's DiarrheaTherapeutics Revenue Market Share by Geographic Region (2020-2025)
Table 32. GlobalTraveler's DiarrheaTherapeutics Sales by Country/Region (2020-2025) & (K Units)
Table 33. GlobalTraveler's DiarrheaTherapeutics Sales Market Share by Country/Region (2020-2025)
Table 34. GlobalTraveler's DiarrheaTherapeutics Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. GlobalTraveler's DiarrheaTherapeutics Revenue Market Share by Country/Region (2020-2025)
Table 36. AmericasTraveler's DiarrheaTherapeutics Sales by Country (2020-2025) & (K Units)
Table 37. AmericasTraveler's DiarrheaTherapeutics Sales Market Share by Country (2020-2025)
Table 38. AmericasTraveler's DiarrheaTherapeutics Revenue by Country (2020-2025) & ($ millions)
Table 39. AmericasTraveler's DiarrheaTherapeutics Sales byType (2020-2025) & (K Units)
Table 40. AmericasTraveler's DiarrheaTherapeutics Sales by Application (2020-2025) & (K Units)
Table 41. APACTraveler's DiarrheaTherapeutics Sales by Region (2020-2025) & (K Units)
Table 42. APACTraveler's DiarrheaTherapeutics Sales Market Share by Region (2020-2025)
Table 43. APACTraveler's DiarrheaTherapeutics Revenue by Region (2020-2025) & ($ millions)
Table 44. APACTraveler's DiarrheaTherapeutics Sales byType (2020-2025) & (K Units)
Table 45. APACTraveler's DiarrheaTherapeutics Sales by Application (2020-2025) & (K Units)
Table 46. EuropeTraveler's DiarrheaTherapeutics Sales by Country (2020-2025) & (K Units)
Table 47. EuropeTraveler's DiarrheaTherapeutics Revenue by Country (2020-2025) & ($ millions)
Table 48. EuropeTraveler's DiarrheaTherapeutics Sales byType (2020-2025) & (K Units)
Table 49. EuropeTraveler's DiarrheaTherapeutics Sales by Application (2020-2025) & (K Units)
Table 50. Middle East & AfricaTraveler's DiarrheaTherapeutics Sales by Country (2020-2025) & (K Units)
Table 51. Middle East & AfricaTraveler's DiarrheaTherapeutics Revenue Market Share by Country (2020-2025)
Table 52. Middle East & AfricaTraveler's DiarrheaTherapeutics Sales byType (2020-2025) & (K Units)
Table 53. Middle East & AfricaTraveler's DiarrheaTherapeutics Sales by Application (2020-2025) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities ofTraveler's DiarrheaTherapeutics
Table 55. Key Market Challenges & Risks ofTraveler's DiarrheaTherapeutics
Table 56. Key IndustryTrends ofTraveler's DiarrheaTherapeutics
Table 57.Traveler's DiarrheaTherapeutics Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59.Traveler's DiarrheaTherapeutics Distributors List
Table 60.Traveler's DiarrheaTherapeutics Customer List
Table 61. GlobalTraveler's DiarrheaTherapeutics SalesForecast by Region (2026-2031) & (K Units)
Table 62. GlobalTraveler's DiarrheaTherapeutics RevenueForecast by Region (2026-2031) & ($ millions)
Table 63. AmericasTraveler's DiarrheaTherapeutics SalesForecast by Country (2026-2031) & (K Units)
Table 64. AmericasTraveler's DiarrheaTherapeutics Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 65. APACTraveler's DiarrheaTherapeutics SalesForecast by Region (2026-2031) & (K Units)
Table 66. APACTraveler's DiarrheaTherapeutics Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 67. EuropeTraveler's DiarrheaTherapeutics SalesForecast by Country (2026-2031) & (K Units)
Table 68. EuropeTraveler's DiarrheaTherapeutics RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & AfricaTraveler's DiarrheaTherapeutics SalesForecast by Country (2026-2031) & (K Units)
Table 70. Middle East & AfricaTraveler's DiarrheaTherapeutics RevenueForecast by Country (2026-2031) & ($ millions)
Table 71. GlobalTraveler's DiarrheaTherapeutics SalesForecast byType (2026-2031) & (K Units)
Table 72. GlobalTraveler's DiarrheaTherapeutics RevenueForecast byType (2026-2031) & ($ millions)
Table 73. GlobalTraveler's DiarrheaTherapeutics SalesForecast by Application (2026-2031) & (K Units)
Table 74. GlobalTraveler's DiarrheaTherapeutics RevenueForecast by Application (2026-2031) & ($ millions)
Table 75. Salix Pharmaceuticals Basic Information,Traveler's DiarrheaTherapeutics Manufacturing Base, Sales Area and Its Competitors
Table 76. Salix PharmaceuticalsTraveler's DiarrheaTherapeutics Product Portfolios and Specifications
Table 77. Salix PharmaceuticalsTraveler's DiarrheaTherapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Salix Pharmaceuticals Main Business
Table 79. Salix Pharmaceuticals Latest Developments
Table 80. P&G Basic Information,Traveler's DiarrheaTherapeutics Manufacturing Base, Sales Area and Its Competitors
Table 81. P>raveler's DiarrheaTherapeutics Product Portfolios and Specifications
Table 82. P>raveler's DiarrheaTherapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. P&G Main Business
Table 84. P&G Latest Developments
Table 85. Johnson & Johnson Basic Information,Traveler's DiarrheaTherapeutics Manufacturing Base, Sales Area and Its Competitors
Table 86. Johnson & JohnsonTraveler's DiarrheaTherapeutics Product Portfolios and Specifications
Table 87. Johnson & JohnsonTraveler's DiarrheaTherapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Johnson & Johnson Main Business
Table 89. Johnson & Johnson Latest Developments
Table 90. Otsuka Pharma Basic Information,Traveler's DiarrheaTherapeutics Manufacturing Base, Sales Area and Its Competitors
Table 91. Otsuka PharmaTraveler's DiarrheaTherapeutics Product Portfolios and Specifications
Table 92. Otsuka PharmaTraveler's DiarrheaTherapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Otsuka Pharma Main Business
Table 94. Otsuka Pharma Latest Developments
Table 95. Valneva Basic Information,Traveler's DiarrheaTherapeutics Manufacturing Base, Sales Area and Its Competitors
Table 96. ValnevaTraveler's DiarrheaTherapeutics Product Portfolios and Specifications
Table 97. ValnevaTraveler's DiarrheaTherapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Valneva Main Business
Table 99. Valneva Latest Developments
Table 100. Shanghai United Cell Basic Information,Traveler's DiarrheaTherapeutics Manufacturing Base, Sales Area and Its Competitors
Table 101. Shanghai United CellTraveler's DiarrheaTherapeutics Product Portfolios and Specifications
Table 102. Shanghai United CellTraveler's DiarrheaTherapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Shanghai United Cell Main Business
Table 104. Shanghai United Cell Latest Developments
Table 105. PaxVax Basic Information,Traveler's DiarrheaTherapeutics Manufacturing Base, Sales Area and Its Competitors
Table 106. PaxVaxTraveler's DiarrheaTherapeutics Product Portfolios and Specifications
Table 107. PaxVaxTraveler's DiarrheaTherapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. PaxVax Main Business
Table 109. PaxVax Latest Developments
Table 110. Livzon Basic Information,Traveler's DiarrheaTherapeutics Manufacturing Base, Sales Area and Its Competitors
Table 111. LivzonTraveler's DiarrheaTherapeutics Product Portfolios and Specifications
Table 112. LivzonTraveler's DiarrheaTherapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Livzon Main Business
Table 114. Livzon Latest Developments
Table 115. Immuron Basic Information,Traveler's DiarrheaTherapeutics Manufacturing Base, Sales Area and Its Competitors
Table 116. ImmuronTraveler's DiarrheaTherapeutics Product Portfolios and Specifications
Table 117. ImmuronTraveler's DiarrheaTherapeutics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Immuron Main Business
Table 119. Immuron Latest Developments
LIST OFFIGURES
Figure 1. Picture ofTraveler's DiarrheaTherapeutics
Figure 2.Traveler's DiarrheaTherapeutics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalTraveler's DiarrheaTherapeutics Sales Growth Rate 2020-2031 (K Units)
Figure 7. GlobalTraveler's DiarrheaTherapeutics Revenue Growth Rate 2020-2031 ($ millions)
Figure 8.Traveler's DiarrheaTherapeutics Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9.Traveler's DiarrheaTherapeutics Sales Market Share by Country/Region (2024)
Figure 10.Traveler's DiarrheaTherapeutics Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Immunization
Figure 12. Product Picture of Non-antibiotic Agents
Figure 13. Product Picture of Antibiotics
Figure 14. Product Picture of Anti-Motility Agents
Figure 15. Product Picture of Others
Figure 16. GlobalTraveler's DiarrheaTherapeutics Sales Market Share byType in 2025
Figure 17. GlobalTraveler's DiarrheaTherapeutics Revenue Market Share byType (2020-2025)
Figure 18.Traveler's DiarrheaTherapeutics Consumed in AdultTraveler's Diarrhea
Figure 19. GlobalTraveler's DiarrheaTherapeutics Market: AdultTraveler's Diarrhea (2020-2025) & (K Units)
Figure 20.Traveler's DiarrheaTherapeutics Consumed in ChildrenTraveler's Diarrhea
Figure 21. GlobalTraveler's DiarrheaTherapeutics Market: ChildrenTraveler's Diarrhea (2020-2025) & (K Units)
Figure 22. GlobalTraveler's DiarrheaTherapeutics Sale Market Share by Application (2024)
Figure 23. GlobalTraveler's DiarrheaTherapeutics Revenue Market Share by Application in 2025
Figure 24.Traveler's DiarrheaTherapeutics Sales by Company in 2025 (K Units)
Figure 25. GlobalTraveler's DiarrheaTherapeutics Sales Market Share by Company in 2025
Figure 26.Traveler's DiarrheaTherapeutics Revenue by Company in 2025 ($ millions)
Figure 27. GlobalTraveler's DiarrheaTherapeutics Revenue Market Share by Company in 2025
Figure 28. GlobalTraveler's DiarrheaTherapeutics Sales Market Share by Geographic Region (2020-2025)
Figure 29. GlobalTraveler's DiarrheaTherapeutics Revenue Market Share by Geographic Region in 2025
Figure 30. AmericasTraveler's DiarrheaTherapeutics Sales 2020-2025 (K Units)
Figure 31. AmericasTraveler's DiarrheaTherapeutics Revenue 2020-2025 ($ millions)
Figure 32. APACTraveler's DiarrheaTherapeutics Sales 2020-2025 (K Units)
Figure 33. APACTraveler's DiarrheaTherapeutics Revenue 2020-2025 ($ millions)
Figure 34. EuropeTraveler's DiarrheaTherapeutics Sales 2020-2025 (K Units)
Figure 35. EuropeTraveler's DiarrheaTherapeutics Revenue 2020-2025 ($ millions)
Figure 36. Middle East & AfricaTraveler's DiarrheaTherapeutics Sales 2020-2025 (K Units)
Figure 37. Middle East & AfricaTraveler's DiarrheaTherapeutics Revenue 2020-2025 ($ millions)
Figure 38. AmericasTraveler's DiarrheaTherapeutics Sales Market Share by Country in 2025
Figure 39. AmericasTraveler's DiarrheaTherapeutics Revenue Market Share by Country (2020-2025)
Figure 40. AmericasTraveler's DiarrheaTherapeutics Sales Market Share byType (2020-2025)
Figure 41. AmericasTraveler's DiarrheaTherapeutics Sales Market Share by Application (2020-2025)
Figure 42. United StatesTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 43. CanadaTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 44. MexicoTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 45. BrazilTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 46. APACTraveler's DiarrheaTherapeutics Sales Market Share by Region in 2025
Figure 47. APACTraveler's DiarrheaTherapeutics Revenue Market Share by Region (2020-2025)
Figure 48. APACTraveler's DiarrheaTherapeutics Sales Market Share byType (2020-2025)
Figure 49. APACTraveler's DiarrheaTherapeutics Sales Market Share by Application (2020-2025)
Figure 50. ChinaTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 51. JapanTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 52. South KoreaTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 53. Southeast AsiaTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 54. IndiaTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 55. AustraliaTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 56. ChinaTaiwanTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 57. EuropeTraveler's DiarrheaTherapeutics Sales Market Share by Country in 2025
Figure 58. EuropeTraveler's DiarrheaTherapeutics Revenue Market Share by Country (2020-2025)
Figure 59. EuropeTraveler's DiarrheaTherapeutics Sales Market Share byType (2020-2025)
Figure 60. EuropeTraveler's DiarrheaTherapeutics Sales Market Share by Application (2020-2025)
Figure 61. GermanyTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 62.FranceTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 63. UKTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 64. ItalyTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 65. RussiaTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 66. Middle East & AfricaTraveler's DiarrheaTherapeutics Sales Market Share by Country (2020-2025)
Figure 67. Middle East & AfricaTraveler's DiarrheaTherapeutics Sales Market Share byType (2020-2025)
Figure 68. Middle East & AfricaTraveler's DiarrheaTherapeutics Sales Market Share by Application (2020-2025)
Figure 69. EgyptTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 70. South AfricaTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 71. IsraelTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 72.TurkeyTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 73. GCC CountriesTraveler's DiarrheaTherapeutics Revenue Growth 2020-2025 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis ofTraveler's DiarrheaTherapeutics in 2025
Figure 75. Manufacturing Process Analysis ofTraveler's DiarrheaTherapeutics
Figure 76. Industry Chain Structure ofTraveler's DiarrheaTherapeutics
Figure 77. Channels of Distribution
Figure 78. GlobalTraveler's DiarrheaTherapeutics Sales MarketForecast by Region (2026-2031)
Figure 79. GlobalTraveler's DiarrheaTherapeutics Revenue Market ShareForecast by Region (2026-2031)
Figure 80. GlobalTraveler's DiarrheaTherapeutics Sales Market ShareForecast byType (2026-2031)
Figure 81. GlobalTraveler's DiarrheaTherapeutics Revenue Market ShareForecast byType (2026-2031)
Figure 82. GlobalTraveler's DiarrheaTherapeutics Sales Market ShareForecast by Application (2026-2031)
Figure 83. GlobalTraveler's DiarrheaTherapeutics Revenue Market ShareForecast by Application (2026-2031)
